Temozolomide-Induced Regression of Hepatic Metastases in a Pituitary Corticotroph Carcinoma with Low O6-Methylguanine-DNA Methyltransferase (MGMT) Expression.

被引:0
|
作者
Annamalai, A. K. [1 ]
Kandasamy, N. [1 ]
Burton, H. [1 ]
Halsall, D. J. [1 ]
Kovacs, K. [2 ]
Dean, A. [1 ]
Antoun, N. [1 ]
Cheow, H. K. [1 ]
Jefferies, S. [1 ]
Chatterjee, V. K. K. [1 ]
Simpson, H. L. [1 ]
Kirollos, R. W. [1 ]
Pickard, J. D. [1 ]
Burnet, N. [1 ]
Gurnell, M. [1 ]
机构
[1] Addenbrookes Hosp, Cambridge, England
[2] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
    McCormack, Ann I.
    McDonald, Kerrie L.
    Gill, Anthony J.
    Clark, Susan J.
    Burt, Morton G.
    Campbell, Kirsten A.
    Braund, Wilton J.
    Little, Nicholas S.
    Cook, Raymond J.
    Grossman, Ashley B.
    Robinson, Bruce G.
    Clifton-Bligh, Roderick J.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (02) : 226 - 233
  • [2] O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
    Salehi, Fateme
    Scheithauer, Bernd W.
    Kovacs, Kalman
    Horvath, Eva
    Syro, Luis V.
    Sharma, Soniya
    Manoranjan, Branavan
    Cusimano, Michael
    NEUROSURGERY, 2012, 70 (02) : 491 - 496
  • [4] Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression
    Zhao, Yachao
    Xiao, Zheng
    Chen, Wenna
    Yang, Jinsheng
    Li, Tao
    Fan, Bo
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2313 - 2322
  • [5] Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O6-methylguanine-DNA methyltransferase (MGMT) expression
    Zhu, Zhongling
    Du, Shuangshuang
    Ding, Fengxia
    Guo, Shanshan
    Ying, Guoguang
    Yan, Zhao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3299 - 3308
  • [6] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Xiaoyin Jiang
    David A. Reardon
    Annick Desjardins
    James J. Vredenburgh
    Jennifer A. Quinn
    Alan D. Austin
    James E. Herndon
    Roger E. McLendon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2013, 114 : 135 - 140
  • [7] O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
    Jiang, Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Quinn, Jennifer A.
    Austin, Alan D.
    Herndon, James E., II
    McLendon, Roger E.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 135 - 140
  • [8] RELATIONSHIP BETWEEN CLINICAL OUTCOME AND EXPRESSION OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE (MGMT) IN MEDULLOBLASTOMA
    Kurimoto, Tomoko
    Kondo, Akihide
    Sakaguchi, Sachi
    Fujimura, Junya
    Saito, Masahiro
    Arakawa, Takashi
    Arai, Hajime
    Shimizu, Toshiaki
    NEURO-ONCOLOGY, 2014, 16 : 77 - 78
  • [9] O6-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
    Hiddinga, Birgitta I.
    Pauwels, Patrick
    Janssens, Annelies
    van Meerbeeck, Jan P.
    LUNG CANCER, 2017, 107 : 91 - 99
  • [10] Towards more specific O6-methylguanine-DNA methyltransferase (MGMT) inactivators
    Lopez, Sergio
    Margison, Geoffrey P.
    McElhinney, R. Stanley
    Cordeiro, Alessandra
    McMurry, T. Brian H.
    Rozas, Isabel
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (05) : 1658 - 1665